Us News

Mara sold Bitcoin to fund the repurchase of about $1 billion in convertible senior notes at a discount.

On Tuesday, Robin Energy announced a tender offer to repurchase up to one million shares at $3 per share, representing a 170% upside from the stock’s closing price on Monday.

Wave Life Sciences’ interim data from the Phase 1 trial of its obesity drug showed 1% reduction in total body weight in six months, a figure that left retail investors disappointed.

In the fourth quarter, Pony.ai reported an 18% drop in total revenue, though the figure still came in ahead of Street estimates, according to Fiscal.ai data.

The Independent Data Monitoring Committee reviewed interim data from 183 evaluable patients, about half of the 366 participants enrolled in the Phase 2b study.

The company said its Phase 3 trial to treat diabetic retinopathy met its primary endpoint.

Analyst upgrades and data center-driven growth expectations are adding to the bullish momentum.

Barclays warned that disruptions in Hormuz could remove 13-14 million bpd, with Brent possibly rising toward $110 if the disruptions persist.

Sentiment was also lifted by expectations tied to the Golden Dome missile-defense initiative, which could boost demand for satellite and space infrastructure.

The recent merger shifts the company beyond its legacy business into sports media, live events, and branded experiences.

Data from Stocktwits shows that traders remain ‘extremely bearish’ on SPY and QQQ.

Merck’s acquisition of Terns underscores strong big-pharma demand for blood-cancer assets, as Pfizer also expands its oncology pipeline.

According to Stocktwits data, retail chatter around CELH stock has risen 2356% over the last three months.

Databricks is among DXYZ’s holdings expected to pursue an IPO this year, with Saxo noting that the company sits “at the centre of the enterprise data-and-AI stack.”

Among Thursday’s catalysts are initial jobless claims data and remarks from several Federal Reserve officials.

The firm registered two new trials combining Anktiva with off-the-shelf iNKT cell therapy in adults with pneumonia, including those with sepsis or ARDS.

The FDA approved Corcept’s Relacorilant well ahead of its previously expected decision date of July 11, 2026.

TruGolf Holdings announced a 1-for-10 reverse stock split, its second share consolidation in less than a year.

The company said it produced its first kilogram of 99.9% pure terbium oxide, just months after producing another heavy rare-earth metal domestically.

The U.S. Food and Drug Administration indicated that a single Phase 3 trial of QRX003 could be enough to support approval in the U.S.

The company began Phase I operations under its joint venture with Maddox Defense, which includes setting up a defense manufacturing facility in Texas.

The biotech firm’s Phase 1/2 trial data for its gene-editing therapy BEAM-302 showed marked improvement in patients with AAT deficiency.

The proposal needs the backing of Senate Majority Leader John Thune and the approval of President Donald Trump, the report added.

Analyst says stock stands out as just one of two Delaware Basin pure-play Exploration and Production companies

Analysts said the war risk premium is still ebbing and flowing, with some expecting stabilization if escalation risks ease.

Despite the bounce, data from Stocktwits shows that traders remain ‘extremely bearish’ on SPY and QQQ.

The analyst said that Arm's new strategy positions the firm between hyperscaler-built custom chips and traditional x86 servers, challenging Intel and AMD.

Analyst estimates suggest SLS may offer 73% upside, versus 16% for TERN, despite takeover momentum supporting TERN’s shares.

The FDA warning letter cited television advertising and podcast remarks suggesting broader cancer uses beyond Anktiva’s approved indication.

VCX traded over 16x its net asset value, signaling strong investor demand for pre-IPO exposure.

Energy remained the key driver, with Brent crude rising 4.6% to $104 and WTI gaining 4.8% to $92.

The SpaceX IPO could raise over $75 billion, potentially making it the largest U.S. listing ever and exceeding last year's total IPO proceeds.

While brokerages have generally been bullish on the stock, Eli Lilly shares have declined nearly 10% over the past week.

The FDA said claims made by founder Patrick Soon-Shiong in a TV advertisement and podcast were “misleading.”

Actelis Networks signed an all-stock deal to acquire Israel-based Exaware to enter the data center networking market.

Karyopharm drew strong retail interest after reporting Phase 3 results for its rare bone marrow cancer treatment and announcing a $30 million private placement deal.

AZIO secured non-refundable customer deposits covering about 42% of its $108 million GPU infrastructure pipeline.

The AI-based entertainment company terminated its share sale agreement with Alliance Global Partners after selling around 5.9 million shares under the deal.

The company said it expects first production of gold in late 2028 at its Bilboes gold project in Zimbabwe.

Small-cap explorers, including TPET, EONR, BATL and INDO outperformed large-cap energy names amid geopolitical supply concerns.

The comments come amid the firm’s strategy to position Anktiva as a platform immunotherapy that works along with vaccines, checkpoint inhibitors and chemotherapy.

Data from Stocktwits indicated that retail sentiment has remained bearish on SPY and QQQ for over a week.

AMC said improving box office trends support expectations that 2026 could become the biggest year for theatrical attendance since 2019, helped by a stronger upcoming film slate.

The move comes as investors shift focus toward AI infrastructure backbone providers, with Vertiv recently added to the S&P 500 alongside peers.

On Thursday, TMC CEO Gerard Barron will present the commercial case for deep-sea mining at a hearing held by the House Science, Space and Technology Subcommittee on Environment.

President Donald Trump’s comments briefly lifted stocks, but escalating tensions with Iran and oil supply fears continue to cloud the outlook.

VCX’s portfolio is heavily concentrated in AI and data infrastructure, which together account for roughly two-thirds of assets.

LUNR is drawing retail optimism as investors bet on a NASA contract for a lunar terrain vehicle.

Netgear shares surged in overnight trading after U.S. regulators blocked approval of new foreign-made consumer routers over cybersecurity risks.

Traders flagged unusual futures activity ahead of Trump’s announcement, including $1.5 billion in S&P futures and $580 million in oil contracts.